Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2024-07-25 Board/Management Inform…
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Directorate Changes
Board/Management Information Classification · 1% confidence The document is a formal announcement released via RNS (Regulatory News Service), indicated by the 'RNS Number' and the concluding boilerplate text referencing RNS and the London Stock Exchange. The core content explicitly announces changes in the company's board of directors: the appointment of a new Chairman, an Executive Director, and a proposed CEO, along with details about a departing director. This content directly matches the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is management changes, making MANG the most precise classification over the general RNS fallback.
2024-07-25 English
Proposed Director Appointment
Board/Management Information Classification · 1% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the Financial Conduct Authority (FCA). The content explicitly announces the 'Proposed Director Appointment' of Cathy Tralau-Stewart as an Executive Director. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. It is not a full financial report (10-K, IR), a proxy statement (DEF 14A), or a general regulatory filing (RNS) since a more specific category exists.
2024-07-03 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is announcing the 'Result of AGM' (Annual General Meeting) held earlier today. It mentions that all resolutions were duly passed except for one. This directly relates to the outcomes of a shareholder meeting. The definition for AGM Information (AGM-R) covers 'Presentations and materials shared during the Annual General Meeting (AGM)'. While this is the *result* rather than the presentation itself, in the context of filing types, results of the AGM are most closely associated with AGM materials or the voting results (DVA). Since the document is an announcement summarizing the outcome of the AGM, and DVA is specifically 'Official results from shareholder votes at any general meeting (AGM or EGM)', DVA is the most precise fit. However, AGM-R covers general AGM information. Given the content is the result summary, DVA is highly relevant, but AGM-R is also a strong candidate covering the event itself. Since the document is a brief announcement (3649 chars) about the AGM outcome, and DVA specifically covers 'Official results from shareholder votes', I will select DVA as the primary classification for the voting outcome announcement. If DVA were not available, AGM-R would be the next best fit.
2024-06-20 English
Directorate Change
Board/Management Information Classification · 1% confidence The document is a short announcement filed via RNS (London Stock Exchange news service). The primary content is the announcement of a 'Directorate Change'—specifically, the resignation of Kevin Cox as Chairman and Director with immediate effect. This directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the specific content is about management change, making MANG the most precise classification over the general RNS fallback.
2024-06-19 English
Inaphaea Contract Award
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 5993S' and concludes with standard boilerplate text indicating it is provided by 'RNS, the news service of the London Stock Exchange.' RNS (Regulatory News Service) filings are used for official company announcements in the UK. The content itself is a business update regarding a contract award ('Inaphaea Contract Award') and includes a statement that the information constitutes 'inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014'. This is a general, non-periodic, material business announcement that does not fit the specific categories like 10-K (Annual Report), ER (Earnings Release), or DIV (Dividend Notice). Since it is a regulatory announcement distributed via RNS that doesn't fit a more specific category (like DIRS, MANG, or CAP), the most appropriate classification is the general regulatory filing category.
2024-06-17 English
Investor Webinar
Report Publication Announcement Classification · 1% confidence The document is identified by the RNS Number header and contains an announcement from ValiRx Plc dated May 28, 2024. The core content is an invitation to an 'Investor Webinar' scheduled for June 3, 2024, including details on registration and Q&A. This is a general, time-sensitive communication to investors about an upcoming event, not a full financial report (like 10-K or IR), a specific voting result (DVA), or a management change (MANG). Since it is a formal announcement distributed via RNS (the news service of the London Stock Exchange, explicitly mentioned at the end), and it doesn't fit neatly into the other specific categories like ER, DIV, or CAP, it falls best under the general regulatory announcement category, RNS, or potentially as a precursor to an Investor Presentation (IP) if the webinar content was a presentation. Given the nature of announcing an interactive Q&A session, RNS is the most appropriate general classification for this type of market communication.
2024-05-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.